Harrisburg, NC -- (SBWire) -- 10/21/2020 --The Therapeutic Proteins Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

The global therapeutic proteins market was valued at about $93.14 billion in 2018 and is expected to grow to $172.87 billion at a CAGR of 16.7% through 2022.

Inquire for a Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/05072013690/therapeutic-proteins-global-market-report-2020-including-1-by-product-type-insulin-fusion-protein-erythropoietin-interferon-human-growth-hormone-follicle-stimulating-hormone-2-by-application-metabolic-disorders-immunologic-disorders-hematological-disorders-cancer-hormonal-disorders-genetic-disorders-others-covering-abbott-laboratories-amgen-inc-baxter-international-inc-eli-lilly-and-company-f-hoffmann-la-roche-ltd/inquiry?source=releasewire&Mode=07

Advance technologies for protein-based drug development drives the therapeutic proteins market. Therapeutic proteins cannot be synthesized chemically, they need to be produced by genetic engineering and recombinant DNA technology in living cells or organisms. Protein-engineering platform technologies such as glycoengineering, pegylation, Fc-fusion, albumin fusion, albumin drug conjugation help to increase the production yield, product purity, circulating half-life, targeting, and functionality of therapeutic protein drugs. Belimumab, ipilimumab, taliglucerase alfa, albiglutide, coagulation factor IX recombinant human are some therapeutic protein drugs developed using protein engineering technologies approved by FDA in the past five years.

Increasing biosimilar drugs in global market decline the growth of the therapeutic proteins market. Patent expiry of therapeutic proteins such as monoclonal antibodies give space for entry of biosimilar. In EU, AbbVie evidenced patent expiration of Humira (adalimumab) in 2018, five biosimilar of Humira from Mylan, Amgen, Sandoz, Samsung Bioepis received drug approvals from European commission to enter the EU market. These cost-effective treatments similar to original biologics decline the revenue and sales of therapeutic proteins.

Monoclonal antibody drug approvals are increasing in the protein therapeutic segment. Chronic diseases such as cancer, immunological disorders are well treated with monoclonal antibodies. Monoclonal antibodies are dominant and well-established product class in the protein therapeutic segment with more safety and immunogenicity than antibodies. Cell-based expression systems such as Chinese hamster ovary (CHO) mammalian cell expression system with latest technologies increased the productivity of monoclonal antibodies by overcoming the problems associated with earlier antibody drugs. In last five years, FDA approved 213 drugs, among them 44 are monoclonal antibodies. In 2018, twelve monoclonal antibodies were approved by FDA for the treatment of cancer and immunological disorders.

Scope of the Report:

Markets Covered: 1) By Product Type: Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone 2) By Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others

Companies Mentioned: Abbott Laboratories, Amgen Inc, Baxter International Inc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, Therapeutic Proteins indicators comparison.

Browse the Report Description And TOC:

https://www.marketinsightsreports.com/reports/05072013690/therapeutic-proteins-global-market-report-2020-including-1-by-product-type-insulin-fusion-protein-erythropoietin-interferon-human-growth-hormone-follicle-stimulating-hormone-2-by-application-metabolic-disorders-immunologic-disorders-hematological-disorders-cancer-hormonal-disorders-genetic-disorders-others-covering-abbott-laboratories-amgen-inc-baxter-international-inc-eli-lilly-and-company-f-hoffmann-la-roche-ltd?source=releasewire&Mode=07

Influence of the Therapeutic Proteins Market Report:

-Comprehensive assessment of all opportunities and risks in the Therapeutic Proteins market.
-The detailed study of business strategies for the growth of the Therapeutic Proteins market-leading players.
-Conclusive study about the growth plot of the Therapeutic Proteins market for forthcoming years.
-In-depth understanding of Therapeutic Proteins market-particular drivers, constraints, and major micro markets.
-Favorable impression inside vital technological and market latest trends striking the Therapeutic Proteins market.

What are the market factors that are explained in the report?

-Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

-Analytical Tools: The Global Therapeutic Proteins Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter's five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please connect with our sales team (sales@marketinsightsreports.com ).

Note: All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

About MarketInsightsReports
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com